Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication
Reseña (Review)
Effects of Pharmacological and Psychological Treatments on Depressive Symptoms in Body Dysmorphic Disorder: A Systematic Review and Meta-Analysis
Purpose of review: This systematic review and meta-analysis evaluated the effects of pharmacological and psychological treatments on depressive symptoms in individuals with body dysmorphic disorder (BDD). The primary objective was to assess treatment-related changes in depressive symptom severity among patients with BDD, while evidence regarding dysmorphic symptoms and combined interventions was reviewed narratively and should be interpreted with caution. Recent findings: Across 46 studies (N=2,227), evidence suggests antidepressants—especially SSRIs—substantially reduce depressive symptoms. Cognitive-behavioral therapy (CBT) also shows large effects, though variability across trials remains high. Most research includes small samples and heterogeneous designs, underscoring the need for consistency. Summary: Pharmacological treatment yielded a pooled standardized mean difference (SMD) of −0.96 (95% CI [−1.37,−0.54], p < 0.001), with SSRIs showing the greatest improvement (SMD =−1.16). CBT demonstrated comparable efficacy (SMD = −1.12), remaining significant after bias correction (SMD = −0.65). Combined approaches may provide optimal outcomes. Future research should focus on large, standardized RCTs evaluating functional recovery and suicide risk reduction.